SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

pharmacology chemotherapy

» Start this Course
(Practice similar questions for free)
Question:

Pantimumab

Author: Suzuki



Answer:

Panitumumab is a fully human monoclonal antibody directed against the EGFR; it is approved for refractory metastatic colorectal cancer.


0 / 5  (0 ratings)

1 answer(s) in total

Author

Suzuki
Suzuki